当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析

云南白药

(000538)

  

流通市值:980.77亿  总市值:987.23亿
流通股本:17.73亿   总股本:17.84亿

云南白药(000538)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润41.23亿元,每股收益2.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益3990536.04万元,未分配利润1810214.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产5378429.32万元,负债1387893.28万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入39,111,292,15629,688,532,074.4420,309,372,850.0710,512,750,996.14
营业总成本35,082,749,923.9725,655,346,434.6417,462,566,820.499,079,602,330.72
营业利润4,830,506,110.424,873,377,249.693,313,345,408.991,730,180,725.55
利润总额4,818,011,756.664,863,763,288.093,303,279,659.051,727,153,106.1
净利润4,122,561,096.494,122,506,023.562,826,258,821.441,515,723,471.89
其他综合收益-21,847,821.78-27,756,402.56-28,749,435.386,561,595.3
综合收益总额4,100,713,274.714,094,749,6212,797,509,386.061,522,285,067.19
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计36,315,565,849.9335,530,489,472.8534,269,578,693.0836,816,455,567.36
非流动资产合计17,468,727,33417,801,859,703.5817,656,869,982.2617,916,341,207.1
资产总计53,784,293,183.9353,332,349,176.4351,926,448,675.3454,732,796,774.46
流动负债合计12,737,778,898.8112,355,517,114.1512,224,993,528.3213,478,564,983.74
非流动负债合计1,141,153,902.91,089,369,438.721,105,020,728.551,202,122,848.74
负债合计13,878,932,801.7113,444,886,552.8713,330,014,256.8714,680,687,832.48
归属于母公司股东权益合计39,879,122,031.5139,886,256,579.8538,597,910,179.1840,029,274,479.88
股东权益合计39,905,360,382.2239,887,462,623.5638,596,434,418.4740,052,108,941.98
负债和股东权益合计53,784,293,183.9353,332,349,176.4351,926,448,675.3454,732,796,774.46
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计41,332,606,952.2430,404,991,051.1820,949,301,997.959,778,633,385.2
经营活动现金流出小计37,829,864,604.2227,815,404,574.0718,697,350,627.859,044,889,182.74
经营活动产生的现金流量净额3,502,742,348.022,589,586,477.112,251,951,370.1733,744,202.46
投资活动现金流入小计4,973,097,122.263,302,436,757.91,348,422,562.65557,474,854.98
投资活动现金流出小计4,454,516,459.622,768,354,686.281,041,333,795.16873,108,512.9
投资活动产生的现金流量净额518,580,662.64534,082,071.62307,088,767.49-315,633,657.92
筹资活动现金流入小计1,378,858,273.49904,123,995.03592,248,791.91235,590,426.42
筹资活动现金流出小计4,296,900,513.084,035,262,550.793,699,949,755.66104,313,436.51
筹资活动产生的现金流量净额-2,918,042,239.59-3,131,138,555.76-3,107,700,963.75131,276,989.91
汇率变动对现金及现金等价物的影响2,324,684.955,005,521.315,239,164.08-5,255,965.79
现金及现金等价物净增加额1,105,605,456.02-2,464,485.72-543,421,662.08544,131,568.66
期末现金及现金等价物余额14,151,765,468.4913,043,695,526.7512,502,738,350.3913,590,291,581.13
最新报告期:2024-04-15
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
西南证券阮雯,杜向阳2.492.773.042024-04-15
兴业证券孙媛媛,董晓洁2.522.783.052024-04-09
浙商证券孙建,吴天昊2.552.863.162024-04-06
中金公司朱言音2.512.76--2024-04-05
华兴证券赵冰,徐浩瀚2.532.702.992024-04-03
TOP↑